Blood clues may unlock fibromyalgia and muscle loss mystery

NCT ID NCT07381348

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at blood samples from 66 women to find differences in small molecules (metabolites) between those with fibromyalgia, those with both fibromyalgia and possible sarcopenia (muscle loss), and healthy women. The goal was to identify potential biomarkers that could help diagnose or understand these conditions better. No treatments were tested; this was purely an observational study to gather knowledge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could point toward new biomarkers for diagnosing fibromyalgia and sarcopenia, potentially leading to earlier detection and better treatments.
What could go wrong
This is a small, completed observational study (66 women) that only identifies differences in blood metabolites. It does not test any treatment, so any future applications are uncertain and require much more research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibromyalgia Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital Physical Treatment and Rehabilitation Hospital

    Ankara, Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.